LLMpediaThe first transparent, open encyclopedia generated by LLMs

Bruce Reitz

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: heart-lung transplant Hop 4
Expansion Funnel Raw 49 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted49
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Bruce Reitz
NameBruce Reitz
Birth date10 February 1944
Birth placeWashington, D.C., United States
NationalityAmerican
FieldsCardiothoracic surgery, Transplant surgery
WorkplacesStanford University School of Medicine, Johns Hopkins Hospital
Alma materMassachusetts Institute of Technology, Johns Hopkins School of Medicine
Known forFirst successful heart–lung transplant
AwardsAmerican Heart Association Research Achievement Award, American Association for Thoracic Surgery Lillehei Prize

Bruce Reitz. He is an American cardiothoracic surgeon renowned for performing the world's first successful combined heart–lung transplant in 1981. His pioneering work established a definitive surgical treatment for patients with end-stage cardiopulmonary disease and opened the field of multi-organ thoracic transplantation. Reitz's career has been closely associated with Stanford University, where he held significant leadership positions and advanced the disciplines of cardiac surgery and transplant immunology.

Early life and education

Born in Washington, D.C., he demonstrated an early aptitude for the sciences. He pursued his undergraduate education at the Massachusetts Institute of Technology, earning a degree in life sciences before entering medical school. He received his M.D. from the prestigious Johns Hopkins School of Medicine, a institution known for its rigorous clinical training. Following medical school, he completed his internship and residency in general surgery at the Johns Hopkins Hospital, laying a foundational surgical skill set. His training continued with a residency in cardiothoracic surgery at Stanford University Medical Center, where he came under the mentorship of pioneering surgeon Norman Shumway.

Medical career and research

His early research focused on the immunology of organ transplantation, particularly the challenges of graft rejection in heart transplant recipients. Working within Norman Shumway's renowned laboratory at Stanford University, he investigated pharmacological strategies for immunosuppression, which were critical for improving transplant outcomes. His experimental work often utilized primate models to study the physiology of transplanted organs and the effects of drugs like cyclosporine. This research directly informed clinical protocols and was instrumental in the era preceding his historic operation. His investigations contributed significantly to the understanding of post-transplant lymphoproliferative disorder and other complications.

Stanford University and leadership roles

He spent the majority of his surgical career as a professor and division chief at Stanford University School of Medicine. He served as the Chair of the Department of Cardiothoracic Surgery at Stanford Health Care for many years, overseeing its growth into a world-leading center. In this role, he trained numerous fellows who went on to direct major cardiac surgery programs across the United States and internationally. He also held the position of Medical Director of the Stanford University Medical Center heart transplant program, guiding its clinical and research missions. His leadership extended to national committees within the American Association for Thoracic Surgery and the United Network for Organ Sharing.

Heart–lung transplantation

The landmark achievement came on March 9, 1981, at Stanford University Medical Center, when he performed the first long-term successful heart–lung transplant on a 45-year-old woman with pulmonary hypertension. This procedure built upon the experimental work of other surgeons, including Christian Barnard and Denton Cooley, but achieved a crucial milestone in patient survival. The success was attributed to meticulous surgical technique, refined organ preservation methods, and the strategic use of the then-new immunosuppressive drug cyclosporine. This operation proved the feasibility of en bloc thoracic organ transplantation and offered a cure for patients with irreversible disease of both the heart and lungs, such as Eisenmenger syndrome.

Awards and honors

His contributions to medicine have been recognized with numerous prestigious awards from major surgical societies. He is a recipient of the American Heart Association's Research Achievement Award for his work in cardiovascular surgery. The American Association for Thoracic Surgery honored him with the Lillehei Prize, named for pioneer C. Walton Lillehei. He has delivered named lectureships, including the Evarts A. Graham Memorial Lecture and the Thomas B. Ferguson Lecture. His professional memberships include fellowship in the American College of Surgeons and election to the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine.

Category:American surgeons Category:Cardiothoracic surgeons Category:Stanford University faculty Category:Transplant surgeons Category:1944 births Category:Living people